Why is Mono Pharmacare falling/rising?

As of 09-Sep, Mono Pharmacare Ltd is experiencing a decline in its stock price, currently at 20.65, which reflects a decrease of 0.9 or 4.18%. The stock has underperformed its sector by 4.81% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 8.22%, and it has seen a significant decline of 40.40% year-to-date. Despite this downturn, there has been a notable increase in investor participation, with delivery volume rising by 275% compared to the 5-day average, indicating some level of interest in the stock despite its negative performance.
Broader Market Context: In comparison to the benchmark, the Sensex has shown a positive return of 1.18% over the past week, while Mono Pharmacare's performance has been significantly negative. This stark contrast highlights the stock's struggles relative to the broader market, which has seen a modest gain of 2.07% over the past month. The ongoing decline in Mono Pharmacare's stock price, coupled with its underperformance against the benchmark, suggests that investor sentiment remains weak, further exacerbated by the lack of positive factors to counterbalance the negative trends observed in its recent performance.